Cell Impact AB (publ) EBIT

Cell Impact AB (publ) (CI-B.ST) currently reports a EBIT of $-120M as of June 2026. That compares with $-98M in the prior-year period — down 23.0% year over year. That is below the sector sector average of $2.6T. Use the charts on this page to explore Cell Impact AB (publ)'s EBIT history and peer comparisons.

Cell Impact AB (publ)'s EBIT decreased from $-98M to $-120M — a 23.0% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Cell Impact AB (publ)'s EBIT of $-120M is lower than the its sector sector average of $2.6T. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Cell Impact AB (publ) reported $-120M in EBIT as of June 2026. That compares with $-98M in the prior-year period — down 23.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-120M, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $2.6T. From there, open related valuation or income-statement pages for Cell Impact AB (publ), and consider following CI-B.ST for alerts when major investors trade the stock.